Scribd
Upload
5 views3 pages

Pharma Sapience New Drug Approval 61859858 2025 06-07-11 52

The document lists various drugs approved by the USFDA from June 2024 onwards, detailing their active ingredients and FDA-approved uses. Notable approvals include treatments for conditions such as dry eye disease, non-small cell lung cancer, and hemophilia. The list encompasses a wide range of therapeutic areas, highlighting advancements in medical treatments.

Uploaded by

bpambalwar
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
5 views3 pages

Pharma Sapience New Drug Approval 61859858 2025 06-07-11 52

The document lists various drugs approved by the USFDA from June 2024 onwards, detailing their active ingredients and FDA-approved uses. Notable approvals include treatments for conditions such as dry eye disease, non-small cell lung cancer, and hemophilia. The list encompasses a wide range of therapeutic areas, highlighting advancements in medical treatments.

Uploaded by

bpambalwar
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 3

🧬USFDA Drug Approvals (June 2024 Onwards)🧬

Drug Name Active Ingredient FDA-approved use


Tryptyr acoltremon Dry eye disease
Emrelis telisotuzumab non-squamous non-small cell lung
vedotin-tllv cancer (NSCLC)
Avmapki Fakzynja avutometinib and KRAS-mutated recurrent low-grade
Co-Pack defactinib serous ovarian cancer (LGSOC)
Imaavy nipocalimab-aahu Generalized myasthenia gravis
penpulimab-kcqx penpulimab-kcqx Non-keratinizing nasopharyngeal
carcinoma (NPC)
Vanrafia atrasentan To reduce proteinuria in adults with
primary immunoglobulin
Qfitlia fitusiran Prevent or reduce the frequency of
bleeding episodes in hemophilia A or
B
Blujepa gepotidacin Uncomplicated urinary tract
infections
Romvimza vimseltinib Symptomatic tenosynovial giant cell
tumor

Gomekli mirdametinib Neurofibromatosis type 1


Journavx suzetrigine Moderate to severe acute pain
Grafapex treosulfan Preparative regimen for allogeneic
hematopoietic stem cell
transplantation for acute myeloid
leukemia and myelodysplastic
syndrome
Datroway datopotamab HR-positive, HER2-negative breast
deruxtecan-dlnk cancer
Alhemo concizumab-mtci Prophylaxis to prevent bleeding
episodes in hemophilia A and B
Alyftrek vanzacaftor, Cystic fibrosis
tezacaftor, and
deutivacaftor
Tryngolza olezarsen Familial chylomicronemia syndrome
Ensacove ensartinib Non-small cell lung cancer
Crenessity crinecerfont Classic congenital adrenal
hyperplasia
Unloxcyt cosibelimab-ipdl Cutaneous squamous cell carcinoma

Bizengri zenocutuzumab-zbco Non-small cell lung cancer and


pancreatic adenocarcinoma
Iomervu iomeprol For use as a radiographic contrast
agent
Rapiblyk landiolol Supraventricular tachycardia
Attruby acoramidis Cardiomyopathy of wild-type or
variant transthyretin-mediated
amyloidosis
Ziihera zanidatamab-hrii Unresectable or metastatic HER2-
positive (IHC 3+) biliary tract cancer
Revuforj revumenib Relapsed or refractory acute
leukemia
Orlynvah sulopenem etzadroxil, Uncomplicated urinary tract
probenecid infections (uUTI)
Vyloy zolbetuximab-clzb Gastric or gastroesophageal junction
adenocarcinoma
Hympavzi marstacimab-hncq Prevent or reduce bleeding episodes
related to hemophilia A or B
Itovebi inavolisib Locally advanced or metastatic
breast cancer
Flyrcado flurpiridaz F 18 Radioactive diagnostic drug for
myocardial ischemia and infarction
Cobenfy xanomeline and Schizophrenia
trospium chloride
Aqneursa levacetylleucine Niemann-Pick disease type C

Miply^a arimoclomol Niemann-Pick disease type C

Ebglyss lebrikizumab-lbkz Moderate-to-severe atopic dermatitis

Lazcluze lazertinib Non-small cell lung cancer

Niktimvo axatilimab-csfr Chronic graft-versus-host disease


(cGVHD)
Livdelzi seladelpar Primary biliary cholangitis (PBC)

Nemluvio nemolizumab-ilto Prurigo nodularis


Yorvipath palopegteriparatide Hypoparathyroidism

Voranigo vorasidenib Grade 2 astrocytoma or


oligodendroglioma
Leqselvi deuruxolitinib Severe alopecia areata
Kisunla donanemab-azbt Alzheimer’s disease
Ohtuvayre ensifentrine Chronic obstructive pulmonary
disease
Piasky crovalimab-akkz Paroxysmal nocturnal
hemoglobinuria
Sofdra sofpironium Primary axillary hyperhidrosis

Iqirvo elafibranor Primary biliary cholangitis


ursodeoxycholic acid
Rytelo imetelstat Low- to intermediate-1 risk
myelodysplastic syndromes

You might also like